Hong Hu Zhu (Hong-Hu Zhu, Honghu Zhu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Topics

Acute Myeloid Leukemia

Aortic Dissection

Extracorporeal Membrane Oxygenation

Top Venues

British journal of haematology

American journal of hematology

Blood cancer journal

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rong Wang, Yue Wu, Ruicong Xue, Ting Shi, Haifeng Gu, Yichen Yang, Weizhen Wu, Yunmei Yang, Shu Sun, Hong Hu Zhu
Personalized therapy guided by single-cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10 AML with extensive extramedullary infiltration: A case report. British journal of haematology (2024)
Jieyu Xu, Jin Peng, Shu Sun, Donghai Wang, Wei Yuan, Xueying Yang, Ting Shi, Rong Wang, Hudan Liu, Pumin Zhang, Hong Hu Zhu
Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia. British journal of haematology 204 (6) (2024)
Jieyu Xu, Jin Peng, Shu Sun, Donghai Wang, Wei Yuan, Xueying Yang, Ting Shi, Rong Wang, Hudan Liu, Pumin Zhang, Hong Hu Zhu
Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia. British journal of haematology (2024)
Xiaosu Zhou, Xue Chen, Jiaqi Chen, Lijun Wen, Zhanglin Zhang, Ya-Zhen Qin, Panxiang Cao, Haizhou Xing, Yingchang Mi, Wei Wang, Guangsen Sen Zhang, Ji Li, Huanling Wu, Zhifen Zhang, Jian Zhang, Zhan Su, Fang Wang, Yang Zhang, Xiaoli Ma, Jiancheng Fang, Ping Wu, Tong Wang, Gaowei Fan, Yang Zhao, David Jin, Xian Zhang, Xiujuan Ma, Qisheng Wu, Zhihua Zhang, Linya Wang, Futian Ma, Xia Xiao, Chengye Wu, Kai Sun, Ruijie Tang, Yun Zhang, Sanyun Wu, Ran Gao, Leping Zhang, Huyong Zheng, Yanli Zhao, Hong Hu Zhu, Daopei Lu, Kai-Yan Liu, Su-Ning Chen, Hongxing Liu
Critical Role of Tripartite Fusion and LBD Truncation in Certain RARA- and all RARG-Related Atypical APL. Blood (2024)
Wen Jin, Yu-Ting Dai, Li Chen, Hong Hu Zhu, Fangyi Dong, Hongming Zhu, Guoyu Meng, Junmin Li, Sai-Juan Chen, Zhu Chen, Hai Fang, Kankan Wang
Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia. Nature communications 15 (1) (2024)
Rong Wang, Yi Zhang, Jie Chang, Huafeng Wang, Yinjun Lou, Min Yang, Gaixiang Xu, Hongyan Tong, Wanzhuo Xie, De Zhou, Juying Wei, Wenyuan Mai, Xiu-Jin Ye, Haitao Meng, Jie Jin, Hong Hu Zhu
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis. Hematological oncology 42 (2) (2024)
Wen Jin, Yu-Ting Dai, Li Chen, Hong Hu Zhu, Fangyi Dong, Hongming Zhu, Guoyu Meng, Junmin Li, Sai-Juan Chen, Zhu Chen, Hai Fang, Kankan Wang
Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia. Nature communications 15 (1) (2024)
Wen Jin, Yu-Ting Dai, Li Chen, Hong Hu Zhu, Fangyi Dong, Hongming Zhu, Guoyu Meng, Junmin Li, Sai-Juan Chen, Zhu Chen, Hai Fang, Kankan Wang
Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia. Nature communications 15 (1) (2024)
Zhen-Yu Xiong, Yao-Jia Shen, Shi-Zhong Zhang, Hong Hu Zhu
A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zhen-Yu Xiong, Yao-Jia Shen, Shi-Zhong Zhang, Hong Hu Zhu
A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Mixue Xie, Ting Shi, Qi Jiang, Yunlu Jia, De Zhou, Hongyan Tong, Jie Jin, Hong Hu Zhu
Chemotherapy with the use of next-generation TKIs based on MRD has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer (2023)
Hong Hu Zhu, Ya-Zhen Qin, Zhang-Lin Zhang, Yong-Jing Liu, Lijun Wen, M James You, Cheng Zhang, Esperanza Such, Hong Luo, Hongjian Yuan, Hong-Sheng Zhou, Hongxing Liu, Ren Xu, Ji Li, Jian-Hu Li, Jian-Ping Hao, Jie Jin, Liang Yu, Jing-Ying Zhang, Li-Ping- Liu, Le-Ping Zhang, Rui-Bin Huang, Shuhong Shen, Sujun Jun Gao, Wei Wang, Xiao-Jing Yan, Xinyou Zhang, Xin Du, Xiaoxia Chu, Yanfang Yu, Yi Wang, Ying-Chang Mi, Ying Lu, Zhen Cai, Zhan Su, David Christopher C Taussig, Suzanne MacMahon, Edward D Ball, Huan-You Wang, John S S Welch, Cheng Cameron Yin, Gautam Borthakur, Miguel Angel Sanz, Hagop M Kantarjian, Jin Yan Huang, Jiong Hu, Su-Ning Chen
A global study for acute myeloid leukemia with RARG rearrangement. Blood advances (2023)
Jie Chang, Yao-Jia Shen, Ting Shi, Hua-Feng Wang, Jie Jin, Hong Hu Zhu
Venetoclax and blinatumomab based chemotherapy-free treatment in a patient with Philadelphia chromosome-negative acute lymphoblastic leukemia. Annals of hematology (2023)
Huafeng Wang, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma, Yi Zhang, Yile Zhou, Jiaying Wu, Xin Huang, Yungui Wang, Huan Xu, Shuanghong Zhu, Hong Hu Zhu, Jie Jin
Venetoclax plus '2 + 5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single-centre retrospective analysis. British journal of haematology (2023)
Yao-Jia Shen, Yi Zhang, Jie Chang, Hua-Feng Wang, Xing-Nong Ye, Li Zhu, Jie Jin, Hong Hu Zhu
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease. Annals of hematology (2023)
De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
Mixue Xie, Ying Lu, Guifang Ouyang, Xue-Ying Li, Ting Shi, Min Yang, Jing Le, Huixian Hu, Li Zhang, Weiying Feng, Haitao Meng, Wenyuan Mai, Juying Wei, Jiejing Qian, Gaixiang Xu, Chunmei Yang, De Zhou, Yin Lin, Suying Qian, Yuemin Kuang, Liming Zhang, Weiguo Zhu, Guoli Yao, Gongqiang Wu, Shao Hu, Xin Huang, Yungui Wang, Hong-Yan Tong, Jie Jin, Hong Hu Zhu
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial. British journal of haematology (2023)
De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
Huai-Yu Wang, Sha Gong, Guo-Hui Li, Ya-Zhou Yao, Yin-Suo Zheng, Xiao-Hong Lu, Su-Hua Wei, Wei-Wei Qin, Hai-Bo Liu, Meng-Chang Wang, Jie-Ying Xi, Li-Mei Chen, Mei Zhang, Xin-Xin Zhang, Hui-Yun Zhang, Cheng-Sheng Zhang, David N Wald, Hong Hu Zhu, Li Liu, Peng-Cheng He
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial). Blood cancer journal 12 (11) (2022)
Qian-Fei Wang, Hong Hu Zhu
APL: Nemo finds its sea anemone. Blood 140 (22) (2022)
Qian Qian Wang, Hua-Feng Wang, Jian-Zhi Zhao, Hua Naranmandura, Jie Jin, Hong Hu Zhu
Venetoclax for arsenic-resistant acute promyelocytic leukaemia. British journal of haematology 197 (5) (2022)
Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang, Jiejing Qian, Yungui Wang, Yongxian Hu, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong Hu Zhu
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia. Blood cancer journal 12 (1) (2022)
Laura Cicconi, Maria Luisa Moleti, Pau Montesinos, Eduardo Rego, Hong Hu Zhu, Hiroyuki Takahashi, Michael Dworzak, Elihu Estey, Anthony Schwarer, Aleksandra Holowiecka, Ombretta Annibali, Roberto Castelli, Milena Mirabile, Mario Angelini, Vladimir Lj Lazarevic, Jeevan Kumar, Giuseppe Avvisati, Carmelo Gurnari, Franco Locatelli, Maria Teresa Teresa Voso, Miguel Angel Sanz, Francesco Lo-Coco, Oussama Abla
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants. Blood cancer journal 11 (10) (2021)
Xiang Zhang, Jiejing Qian, Huafeng Wang, Yungui Wang, Yi Zhang, Pengxu Qian, Yinjun Lou, Jie Jin, Hong Hu Zhu
Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia. Biomarker research 9 (1) (2021)
Jie-Jing Qian, Xiaoxia Hu, Ying Wang, Yi Zhang, Juan Du, Min Yang, Hongyan Tong, Wen-Bin Qian, Juying Wei, Wenjun Yu, Yin-Jun Lou, Liping Mao, Hai Tao Meng, Liang-Shun You, Libing Wang, Xia Li, Xin Huang, Li-Hong Cao, Jian-Zhi Zhao, Xiao Yan Yan, Yu-Bao Chen, Yu Chen, Su-Jiang Zhang, Jie Jin, Jiong Hu, Hong Hu Zhu
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study. Cancer medicine 9 (15) (2020)
Hong Hu Zhu, Meng-Cheng Yang, Feng Wang, Yin-Jun Lou, Jie Jin, Ke Li, Shi-Zhong Zhang
Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia. American journal of hematology 95 (7) (2020)
Huan-Ping Wang, Yi-Le Zhou, Xin Huang, Yi Zhang, Jie-Jing Qian, Jian-Hu Li, Xue-Ying Li, Chen-Ying Li, Yin-Jun Lou, Wen-Yuan Mai, Hai-Tao Meng, Wen-Juan Yu, Hong-Yan Tong, Jie Jin, Hong Hu Zhu
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia. American journal of hematology 96 (3) (2020)
Hong Hu Zhu, Jie-Jing Qian, Wan-Jun Sun, Liang-Shun You, Qian Qian Wang, Hua Naranmandura, Jie Jin
Venetoclax and arsenic showed synergistic anti-leukemia activity in vitro and in vivo for acute myeloid leukemia with the NPM1 mutation. American journal of hematology 95 (3) (2020)
Hong Hu Zhu, Jiong Hu, Francesco Lo-Coco, Jie Jin
The simpler, the better: oral arsenic for acute promyelocytic leukemia. Blood 134 (7) (2019)
Ruidan Xu, Shuyu Yu, Dan Zhu, Xinping Huang, Yuqi Xu, Yimin Lao, Yonglu Tian, Jinfang Zhang, Zefang Tang, Yuanyuan Zhang, Jing Yi, Hong Hu Zhu, Xiaofeng Zheng
hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy. Nature communications 10 (1) (2019)
Hong Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai
Oral arsenic and all-trans retinoic acid for high-risk acute promyelocytic leukemia. Blood 131 (26) (2018)
Ya-Zhen Qin, Xiao-Jun Huang, Hong Hu Zhu
Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia. Leukemia 32 (10) (2018)
Ya-Zhen Qin, Hong Hu Zhu, Qian Jiang, Lan-Ping Xu, Hao Jiang, Yu Wang, Xiao-Su Zhao, Yan-Rong Liu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21). Blood cancer journal 8 (8) (2018)